Interestingly, some studies have also suggested that blocking PD-L1 has a direct effect on cancer cells themselves by reducing the glycolytic activity of tumor cells and increasing glucose levels available in the environment for the TILs [94]. This evidence concerns the gene CD274 and neoplasm.